Effects of lifestyle modification and metformin on irisin and FGF21 among HIV-infected subjects with the metabolic syndrome

Clinical Endocrinology

Volumn 82, Issue 5, 2015, Pages 678-685

  Srinivasa, Suman ^a   Wong, Kimberly ^a   Fitch, Kathleen V ^a   Wei, Jeffrey ^b   Petrow, Eva ^a   Cypess, Aaron M ^a   Torriani, Martin ^a   Grinspoon, Steven K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; FIBROBLAST GROWTH FACTOR 21; FIBRONECTIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN; IRISIN; METFORMIN; PLACEBO; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1; FIBROBLAST GROWTH FACTOR; FNDC5 PROTEIN, HUMAN; HORMONE;

ARTICLE; BROWN ADIPOSE TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE INCREASE; FEMALE; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN TISSUE; INTRAABDOMINAL FAT; KINESIOTHERAPY; LIFESTYLE MODIFICATION; MALE; METABOLIC SYNDROME X; NUTRITIONAL COUNSELING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY QUOTIENT; SUBCUTANEOUS FAT; THERAPY EFFECT; WAIST CIRCUMFERENCE; ADOLESCENT; ADULT; AGED; BODY COMPOSITION; BODY MASS; COMPLICATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFESTYLE; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; YOUNG ADULT;

ADIPOSE TISSUE, BROWN; ADOLESCENT; ADULT; AGED; BODY COMPOSITION; BODY MASS INDEX; FEMALE; FIBROBLAST GROWTH FACTORS; FIBRONECTINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HIV INFECTIONS; HOMEOSTASIS; HORMONES; HUMANS; LIFE STYLE; MALE; METABOLIC SYNDROME X; METFORMIN; MIDDLE AGED; PROSPECTIVE STUDIES; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84927106867     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12582     Document Type: Article

References (26)

1. Fisher, F.M., Kleiner, S., Douris, N., et al,. (2012) FGF21 regulates PGC-1alpha and browning of white adipose tissues in adaptive thermogenesis. Genes & Development, 26, 271-281.
2. Wu, J., Bostrom, P., Sparks, L.M., et al,. (2012) Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell, 150, 366-376.
3. Barbatelli, G., Murano, I., Madsen, L., et al,. (2010) The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation. American Journal of Physiology Endocrinology and Metabolism, 298, E1244-E1253.
4. Ghorbani, M., &, Himms-Hagen, J., (1997) Appearance of brown adipocytes in white adipose tissue during CL 316,243-induced reversal of obesity and diabetes in Zucker fa/fa rats. International Journal of Obesity and Related Metabolic Disorders, 21, 465-475.
5. Barbera, M.J., Schluter, A., Pedraza, N., et al,. (2001) Peroxisome proliferator-activated receptor alpha activates transcription of the brown fat uncoupling protein-1 gene. A link between regulation of the thermogenic and lipid oxidation pathways in the brown fat cell. Journal of Biological Chemistry, 276, 1486-1493.
6. Iglesias, P., Selgas, R., Romero, S., et al,. (2012) Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21. European Journal of Endocrinology, 167, 301-309.
7. Bostrom, P., Wu, J., Jedrychowski, M.P., et al,. (2012) A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature, 481, 463-468.
8. Lee, P., Linderman, J.D., Smith, S., et al,. (2014) Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. Cell Metabolism, 19, 302-309.
9. Torriani, M., Fitch, K., Stavrou, E., et al,. (2012) Deiodinase 2 expression is increased in dorsocervical fat of patients with HIV-associated lipohypertrophy syndrome. Journal of Clinical Endocrinology and Metabolism, 97, E602-E607.
10. Fitch, K., Abbara, S., Lee, H., et al,. (2012) Effects of lifestyle modification and metformin on atherosclerotic indices among HIV-infected patients with the metabolic syndrome. AIDS, 26, 587-597.
11. Nygaard, E.B., Vienberg, S.G., Orskov, C., et al,. (2012) Metformin stimulates FGF21 expression in primary hepatocytes. Experimental Diabetes Research, 2012, 465282.
12. Abate, N., Burns, D., Peshock, R.M., et al,. (1994) Estimation of adipose tissue mass by magnetic resonance imaging: validation against dissection in human cadavers. Journal of Lipid Research, 35, 1490-1496.
13. Abate, N., Garg, A., Coleman, R., et al,. (1997) Prediction of total subcutaneous abdominal, intraperitoneal, and retroperitoneal adipose tissue masses in men by a single axial magnetic resonance imaging slice. American Journal of Clinical Nutrition, 65, 403-408.
14. Xu, J., Lloyd, D.J., Hale, C., et al,. (2009) Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes, 58, 250-259.
15. Bobbert, T., Schwarz, F., Fischer-Rosinsky, A., et al,. (2013) Fibroblast growth factor 21 predicts the metabolic syndrome and type 2 diabetes in Caucasians. Diabetes Care, 36, 145-149.
16. Domingo, P., Gallego-Escuredo, J.M., Domingo, J.C., et al,. (2010) Serum FGF21 levels are elevated in association with lipodystrophy, insulin resistance and biomarkers of liver injury in HIV-1-infected patients. AIDS, 24, 2629-2637.
17. Cuevas-Ramos, D., Almeda-Valdes, P., Meza-Arana, C.E., et al,. (2012) Exercise increases serum fibroblast growth factor 21 (FGF21) levels. PLoS ONE, 7, e38022.
18. Kim, K.H., Kim, S.H., Min, Y.K., et al,. (2013) Acute exercise induces FGF21 expression in mice and in healthy humans. PLoS ONE, 8, e63517.
19. Zhang, M., Liu, Y., Xiong, Z.Y., et al,. (2013) Changes of plasma fibroblast growth factor-21 (FGF-21) in oral glucose tolerance test and effects of metformin on FGF-21 levels in type 2 diabetes mellitus. Endokrynologia Polska, 64, 220-224.
20. Guallar, J.P., Gallego-Escuredo, J.M., Domingo, J.C., et al,. (2008) Differential gene expression indicates that 'buffalo hump' is a distinct adipose tissue disturbance in HIV-1-associated lipodystrophy. AIDS, 22, 575-584.
21. Lloreta, J., Domingo, P., Pujol, R.M., et al,. (2002) Ultrastructural features of highly active antiretroviral therapy-associated partial lipodystrophy. Virchows Archiv, 441, 599-604.
22. Fessel, W., Follansbee, S.B., &, Barker, B., (2000) Ultrastructural findings consistent with brown adipocytes in buffalo humps of HIV-positive patients with fat redistribution syndrome. Antiviral Therapy, 3 (Supp 5), 25.
23. Moreno- Navarrete, J.M., Ortega, F., Serrano, M., et al,. (2013) Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. Journal of Clinical Endocrinology and Metabolism, 98, E769-778.
24. Norheim, F., Langleite, T.M., Hjorth, M., et al,. (2013) The effects of acute and chronic exercise on PGC-1alpha, irisin and browning of subcutaneous adipose tissue in humans. FEBS Journal, 281, 738-749.
25. Hecksteden, A., Wegmann, M., Steffen, A., et al,. (2013) Irisin and exercise training in humans-Results from a randomized controlled training trial. BMC Medicine, 11, 235.
26. Huh, J.Y., Panagiotou, G., Mougios, V., et al,. (2012) FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism, 61, 1725-1738.